drug discovery
ELRIG appoints Del Trezise as chair
April 8, 2025Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma
ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …
Drug discovery and development partnership announced between Apollo Therapeutics and Oxford University
July 31, 2024Clinical Research, Medical Communications, Research and Development Apollo Therapeutics, Internal Medicine, Microbiology, drug development, drug discovery, research
Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford University’s …
Certara to acquire Chemaxon for drug discovery portfolio
July 10, 2024Business Services Certara, Chemaxon, Pharmacy, acquisition, drug discovery
Certara and Chemaxon have announced that they have signed a definitive agreement under which Certara will acquire Chemaxon. The deal …
PeptiDream and Novartis extend peptide discovery collaboration
April 30, 2024Research and Development Novartis, PeptiDream, Pharmacy, collaboration, drug discovery, peptides
PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.
Allumiqs and Prolytix enter partnership for acceleration of drug discovery and development
March 15, 2024Research and Development Allumiqs, Pharmacy, drug discovery, partnership
Allumiqs and Prolytix have announced that they have entered into a long-term, strategic partnership with the aim of providing collaboratinve …
Isomorphic Labs to collaborate with Eli Lilly
January 11, 2024Research and Development AI, Eli Lilly, Isomorphic Labs, Pharmacy, drug discovery
Isomorphic Labs has announced that it has entered into a strategic research collaboration with Eli Lilly and Company, marking the …
Galapagos and BridGene Biosciences enter collaboration for oncology drug discovery
January 4, 2024Research and Development BridGene Biosciences, Galapagos, Oncology, drug discovery, oncology
Galapagos NV and BridGene Biosciences have announced that they have entered into a strategic collaboration and licensing agreement for the …
Exscientia enters AI drug discovery collaboration with Merck KGaA
September 20, 2023Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery
Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …
Recursion and NVIDIA partner for AI-enabled drug discovery developments
July 13, 2023Research and Development AI, Pharmacy, Recursion, drug discovery
Clinical stage biotech company Recursion has announced a $50m investment by NVIDIA, intended to accelerate the development of its AI …
New screening method set to speed up drug discovery in major diseases
July 8, 2021drug discovery
Scientists from the University of Birmingham and the University of Leicester have discovered a new screening method that can test …
PrecisionLife & Cyclica join forces on 30 AI drug discovery programmes
May 17, 2021Sales and Marketing AI, drug discovery
PrecisionLife, a combinatorial analytics company, and Toronto-based drug discovery company, Cyclica, have announced a strategic partnership to co-market and offer …
Facio Therapies announces AI collaboration for FSHD drug design
May 11, 2021Manufacturing and Production AI, drug discovery
Facio Therapies and Iktos have announced a collaboration to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of …
Gilead invests $5.1 billion into Galapagos NV
July 15, 2019Sales and Marketing Galapagos, Gilead, biotech, collaboration, deal, drug discovery, pharma
Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV. The collaboration will see Gilead invest $5.1 …
Amgen agrees to buy Nuevolution for $167 million
May 22, 2019Research and Development Amgen, Cancer, Nuevolution, biotech, drug discovery, immuno-oncology, immunology, pharma
California biotech Amgen has agreed to buy Danish biopharmaceutical company Nuevolution AB for 1.61 billion Swedish crowns ($166.8 million). The …
Celgene inks drug discovery deal worth at least £25m with AI firm Exscientia
March 21, 2019Research and Development Celgene, Exscientia, drug discovery, pharma
Celgene has entered into a new three-year partnership with British artificial intelligence and drug discovery firm Exscientia to the value …
